Most European proton candidates still face critical access shortages
More than 56,000 theoretically eligible European patients lived in areas with no proton access or critical capacity shortages in 2025.
More than 56,000 theoretically eligible European patients lived in areas with no proton access or critical capacity shortages in 2025.
Five-fraction prostate radiotherapy produced 58.6% lower estimated carbon emissions than a 26-fraction schedule, mainly by reducing patient travel.
Commercial insurance, current smoking, single status, and neighborhood disadvantage were independently associated with radiotherapy-related debt sent to collections.